Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-09-01
1995-05-30
Ivy, C. Warren
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
548551, 548571, C07D20712, C07D20714, C07D20706
Patent
active
054202981
ABSTRACT:
The invention concerns pyrrolidine derivatives of the formula ##STR1## wherein Ar.sup.1 is optionally-substituted phenyl, naphthyl or a 10-membered bicyclic heterocyclic moiety containing one or two nitrogen heteroatoms and optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur;
A is a direct link to the group X or A is (1-4C)alkylene;
X is oxy, thio, sulphinyl or sulphonyl;
Ar.sup.2 is phenylene, pyridinediyl, pyrimidinediyl, thiophendiyl, furandiyl or thiazolediyl;
R.sup.1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl;
R.sup.2 is (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, halogeno-(1-4C)alkyl, halogeno-(2-4C)alkenyl, halogeno-(2-4C)alkynyl, (1-4C)alkoxy-(2-4C)alkyl, hydroxy-(2-4C)alkyl, cyano-(1-4C)alkyl, carboxy-(1-4C)alkyl, carbamoyl-(1-4C)alkyl, (1-4C)alkoxycarbonyl-(1-4C)alkyl, N-(1-4C)alkylcarbamoyl-(1-4C)alkyl or N,N-di-(1-4C)alkylcarbamoyl-(1-4C)alkyl; and
n is 1 or 2 and each R.sup.3 is independently hydrogen, hydroxy, (1-4C)alkyl or (1-4C)alkoxy;
or a pharmaceutically-acceptable salt thereof;
processes for their manufacture; pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors.
REFERENCES:
patent: 3083208 (1963-03-01), Wu
patent: 3127415 (1964-03-01), Wu
patent: 4567184 (1986-01-01), Musser et al.
patent: 4625034 (1986-11-01), Weiss et al.
patent: 4631287 (1986-12-01), Chakraborty et al.
patent: 4725619 (1988-02-01), Chakraborty et al.
patent: 4728668 (1988-03-01), Chakraborty et al.
patent: 4794188 (1988-12-01), Musser et al.
patent: 4839369 (1989-06-01), Youssefyeh et al.
patent: 4868193 (1989-09-01), Lee
patent: 4874769 (1989-10-01), Youssefyeh et al.
patent: 5098930 (1992-03-01), Edwards et al.
patent: 5098932 (1992-03-01), Hamon
patent: 5105020 (1992-04-01), Girodeau
patent: 5134148 (1992-07-01), Crawley et al.
patent: 5137913 (1992-08-01), Bird et al.
patent: 5179115 (1993-01-01), Bruneau et al.
patent: 5196419 (1993-03-01), Crawley et al.
patent: 5208259 (1993-05-01), Bird et al.
patent: 5214070 (1993-05-01), Bird et al.
patent: 5217969 (1993-06-01), Bruneau et al.
patent: 5217977 (1993-06-01), Crawley et al.
patent: 5217978 (1993-06-01), Bird
patent: 5219881 (1993-06-01), Hamon
patent: 5221677 (1993-06-01), Crawley et al.
patent: 5225438 (1993-07-01), Dowell et al.
patent: 5234950 (1993-08-01), Edwards et al.
patent: 5236919 (1993-08-01), Crawley et al.
patent: 5236948 (1993-08-01), Waterson
patent: 5240941 (1993-08-01), Bruneau
Wu et al, Chemical Abstracts 57: 12412A (1962).
Mead Johnson, Chemical Abstracts 57: 16566a (1961).
Wu et al, Chemical Abstracts 59: 8709b (1963).
Review, Leukotriene research making prohress, Scripp No. 1613, May 3rd 1991 pp. 25-27.
Laursen et al., Selective 5-lipoxygenase inhibition in ulcerative colitis, The Lancet, vol. 335, pp. 683-685, Mar. 1990.
Edwards Philip N.
Large Michael S.
Ivy C. Warren
M. Mach D. Margaret
Zeneca Limited
Zeneca Pharma S.A.
LandOfFree
Pyrrolidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363317